Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014)
Tandem Diabetes Care (TNDM) reported Non Operating Investment Income of $6529.0 for Q3 2014, up 520.95% quarter-over-quarter from -$1551.0 in Q2 2014.
Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014) Analysis & Trends
Tandem Diabetes Care has reported Non Operating Investment Income for 1 years, with the latest figure at $6529.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | - |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | - |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | - |
| 10 | Tandem Diabetes Care | 1.27 Bn | 696.46 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 6,529.00 |
| Sep 30, 2014 | 6,529.00 |
| Jun 30, 2014 | -1,551.00 |
| Jun 30, 2014 | -1,551.00 |
| Mar 31, 2014 | 13,833.00 |
| Mar 31, 2014 | 13,833.00 |